Summary
Epidemiological studies in ataxia telangiectasia (AT) families have suggested that AT heterozygotes could have an increased cancer risk, especially breast cancer (BC) in women. It has also been suggested that an increased sensibility of AT heterozygotes to the effect of ionizing radiation could be responsible for the increased BC risk. BC relative risk (RR) estimation in AT heterozygotes within families ascertained through AT children is presented here. Family data collected included demographic characteristics, occurrence of cancers, past radiation exposures and blood samples. DNA samples were studied using seven ATM linked microsatellites markers allowing AT haplotypes reconstitution. The relative risk of BC was assessed using French estimated incidence rates. A significant increase risk of BC is found among obligate ATM heterozygotes with a point estimate of 3.32 (P = 0.002). BC relative risk calculated according to age is significantly increased among the obligate ATM heterozygotes female relatives with an age ≤ 44 years (RR = 4.55, P = 0.005). The BC relative risk is statistically borderline among the obligate ATM heterozygote female relatives with an age ≥ 45 years (RR = 2.48, P = 0.08). The estimated BC relative risk among ATM heterozygotes is consistent with previously published data. However, the increased risk is only a little higher than classical reproductive risk factors and similar to the risk associated with a first-degree relative affected by BC.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Aitken, J., Bain, C., Ward, M., Siskind, V. & MacLennan, R. (1995). How accurate is self-reported family history of colorectal cancer? Am J Epidemiol 141: 863–871.
Appleby, J. M., Barber, J. B. P., Levine, E., Varley, J. M., Taylor, A. M. R., Stankovic, T., Heighway, J., Warren, C. & Scott, D. (1997). Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy. Br J Cancer 72: 1546–1549.
Athma, P., Rappaport, R. & Swift, M. (1996). Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet Cytogenet 92: 130–134.
Bebb, G., Glickman, B., Gelmon, K. & Gatti, R. (1997). ‘AT risk’ for breast cancer. Lancet 349: 1784–1785.
Benhamou, E., Laplanche, A., Wartelle, M., Faivre, J., Gignoux, M., Menegoz, F., Robillard, J., Schaffer, P., Schraub, S. & Flamant, R. (1990). Incidence des cancers en France 1978–1982. In Statistiques de santé, INSERM (ed). INSERM: Paris
Bishop, D. T. & Hopper, J. (1997). AT-tributable risk? Nat Genet 15: 226
Børresen, A. L., Andersen, T. I., Tretli, S., Heiberg, A. & Moller, P. (1990). Breast cancer and other cancers in Norwegian families with ataxia-telangiectasia. Genes Chromosomes Cancer 2: 339–403.
Breslow, N. E. & Day, N. E. (1987). The design and analysis of cohort studies. In Statistical Methods in Cancer Research, Davis W (ed). IARC: Lyon
Coleman, M., Douglas, A., Hermon, C. & Peto, J. (1986). Cohort study analysis with a Fortran computer program. Int J Epidemiol 15: 134–137.
De Vathaire, F., Koscielny, S., Rezvani, A., Laplanche, A., Estève, J. & Ferlay, J. (1996). Estimation de l’incidence des cancers en France 1983–1987. In Statistiques de santé, INSERM (ed). INSERM: Paris
Easton, D. F. (1994). Cancer risks in A-T heterozygotes. Int J Radiat Biol 6: S177–182.
FitzGerald, M. G., Bean, J. M., Hegde, S. R., Unsal, H., MacDonald, D. J., Harkin, D. P., Finkelstein, D. M., Isselbacher, K. J. & Haber, D. A. (1997). Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nat Genet 15: 307–310.
Kelsey, J. L. & Horm-Ross, P. L. (1993). Breast cancer: magnitude of the problem and descriptive epidemiology. Epidemiol Rev 15: 7–16.
Laake, K., Odegard, A., Andersen, T. I., Bukholm, I. K., Kaeresen, R., Nesland, J. M., Ottestad, L., Shiloh, Y. & Børresen-Dale, A. L. (1997). Loss of heterozygosity at 11q23.1 in breast carcinomas: indication for involvement of a gene distal and close to ATM. Genes Chromosomes Cancer 18: 175
Morrell, D., Chase, C. L. & Swift, M. (1990). Cancers in 44 families with ataxia-telangiectasia. Cancer Genet Cytogenet 50: 119–123.
Parkin, D. M., Muir, C. S., Whelan, S. L., Gao, Y. T., Ferlay, J. & Powel, J. (1992). Cancer Incidence in Five Continents, Vol 5. IARC: Lyon
Pippard, E. C., Hall, A. J., Barker, D. J. & Bridges, B. A. (1988). Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain. Cancer Res 48: 2929–2932.
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., Ashkenazi, M., Pecker, I., Frydman, M., Harnik, R., Pantanjali, S. R., Simmons, A., Clines, G. A., Sartiel, A., Gatti, R. A., Chessa, L., Sanal, O., Lavin, M. F., Jaspers, N. G. J., Taylor, A. M. R., Arlett, C. F., Miki, T., Weissman, S. H., Lovett, M., Collins, F. S. & Shiloh, Y. (1995). A single ataxia-telangiectasia gene with a product similar to PI-3 kinase. Science 268: 1749–1753.
Shayeghi, M., Seal, S., Regan, J., Collins, N., Barfoot, R., Rahman, N., Ashton, A., Moohan, M., Wooster, R., Owen, R., Bliss, J. M., Stratton, M. E. & Yarnold, J. (1998). Heterozygosity for mutations in the ataxia telangectasia gene is not a major cause of radiotherapy complications in breast cancer patients. Br J Cancer 78: 922–927.
Stankovic, T., Kidd, A. M. J., Sutcliffe, A., McGuire, G. M., Robinson, P., Weber, P., Bedenham, T., Bradwell, A. R., Easton, D. F., Lennox, G. G., Haites, N., Byrd, P. J. & Taylor, A. M. (1998). ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. Am J Hum Genet 62: 334–345.
Swift, M., Reitnauer, P. J., Morrell, D. & Chase, C. L. (1987). Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med 316: 1289–1294.
Swift, M., Morrell, D., Massey, R. B. & Chase, C. L. (1991). Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 325: 1831–1836.
Theis, B., Boyd, N., Lockwood, G. & Trickler, D. (1994). Accuracy of family history in breast cancer patients. Eur J Cancer Prev 3: 321–327.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Janin, N., Andrieu, N., Ossian, K. et al. Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families. Br J Cancer 80, 1042–1045 (1999). https://doi.org/10.1038/sj.bjc.6690460
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690460
Keywords
This article is cited by
-
Increased incidence of pathogenic variants in ATM in the context of testing for breast and ovarian cancer predisposition
Journal of Human Genetics (2022)
-
Cancer risks associated with heterozygous ATM loss of function and missense pathogenic variants based on multigene panel analysis
Breast Cancer Research and Treatment (2022)
-
First international workshop of the ATM and cancer risk group (4-5 December 2019)
Familial Cancer (2022)
-
Severe reaction to radiotherapy for breast cancer as the presenting feature of ataxia telangiectasia
British Journal of Cancer (2012)
-
Association between ATM 5557G>A polymorphism and breast cancer risk: a meta-analysis
Molecular Biology Reports (2012)